Skip to main content

Hives clinical trials at UCLA

3 research studies open to eligible people

Showing trials for
  • (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

    open to eligible people ages 18 years and up

    This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL).

    Los Angeles 5368361, California 5332921 and other locations

  • Barzolvolimab in Participants With Chronic Spontaneous Urticaria

    open to eligible people ages 18 years and up

    The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.

    Los Angeles 5368361, California 5332921 and other locations

  • Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

    open to eligible people ages 18 years and up

    The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.

    Los Angeles 5368361, California 5332921 and other locations

Our lead scientists for Hives research studies include .

Last updated: